A combination of chemoirradiation and chemotherapy for treatment of advanced clear cell adenocarcinoma of the cervix

International Journal of Gynecological Cancer

Volumn 18, Issue 3, 2008, Pages 559-563

  Chan, K K L ^a   Ip, P ^a   Kwong, P ^a   Tam, K F ^a   Ngan, H Y S ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cervical cancer; Chemoirradiation; Clear cell adenocarcinoma; Gemcitabine; Paclitaxel

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; GEMCITABINE; PACLITAXEL;

ADOLESCENT; ADVANCED CANCER; ANAPHYLACTIC SHOCK; ARTICLE; BRACHYTHERAPY; CANCER PALLIATIVE THERAPY; CANCER STAGING; CASE REPORT; CLEAR CELL CARCINOMA; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; INTESTINE OBSTRUCTION; MULTIPLE CYCLE TREATMENT; POOR GENERAL CONDITION; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE FRACTIONATION; TREATMENT INDICATION; TREATMENT RESPONSE; UTERINE CERVIX CARCINOMA;

ADENOCARCINOMA, CLEAR CELL; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOPSY, NEEDLE; BRACHYTHERAPY; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM INVASIVENESS; NEOPLASM STAGING; RARE DISEASES; RISK ASSESSMENT; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 43449120948     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2007.01037.x     Document Type: Article

References (16)

1. Noller KL, Decker DG, Dockery MB et al. Mesonephric (clear cell) carcinoma of the vagina and cervix. A retrospective analysis. Obstet Gynecol 1974 43 : 640 4.
2. Kaminski PF, Maier RC. Clear cell adenocarcinoma of the cervix unrelated to diethylstilbestrol exposure. Obstet Gynecol 1983 62 : 720 7.
3. Reich O, Tamussino K, Lahousen M et al. Clear cell carcinoma of the uterine cervix: pathology and prognosis in surgically treated stage IB-IIB disease in women not exposed in utero to diethylstilbestrol. Gynecol Oncol 2000 76 : 331 5.
4. Hanselaar A, van Loosbroek M, Schuurbiers O, Helmerhorst T, Bulten J, Bernheim J. Clear cell adenocarcinoma of the vagina and cervix. An update of the central Netherlands registry showing twin age incidence peaks. Cancer 1997 79 : 2229 36.
5. Hiroyuki S, Takada T, Sodemoto T, Hoshino H, Saitoh K, Uekusa T. A young woman with clear cell adenocarcinoma of the uterine cervix. Int J Clin Oncol 2003 8 : 399 404.
6. Hanselaar A, Van Leusen N, De Wilde P et al. Clear cell adenocarcinoma of the vagina and cervix. A report of the central Netherlands registry with emphasis on early detection and prognosis. Cancer 1991 67 : 1971 8.
7. Jones WB, Tan LK, Lewis JL Jr. Late recurrence of clear cell adenocarcinoma of the vagina and cervix: a report of three cases. Gynecol Oncol 1993 51 : 266 71.
8. Ding D, Chang F, Yu M. Huge clear cell carcinoma of the cervix in teenager not associated with diethylstilbestrol: a brief case report. Eur J Obstet Gynecol 2004 117 : 115 6.
9. Abu-Rustum NR, Su W, Levine D, Boyd J, Sonoda Y, LaQuaglia M. Pediatric radical abdominal trachelectomy for cervical clear cell carcinoma: a novel surgical approach. Gynecol Oncol 2005 97 : 296 300.
10. Arhens WA, Barron-Rodriquez LP, Mckee M, Rivkees S, Reyes-Mugica M. Clear cell adenocarcinoma of the cervix in a child without in utero exposure to diethylstilbesterol: a case report and review of the literature. Pediatr Dev Pathol 2005 8 : 690 5.
11. Rose PG, Bundy BN, Watkins EB et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Eng J Med 1999 340 : 1144 53.
12. Matias-Guiu X, Lerma E, Prat J. Clear cell tumors of the female genital tract. Semin Diagn Pathol 1997 14 : 233 9.
13. Moore DH, Blessing JA, McQuellon RP et al. Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study. J Clin Oncol 2004 22 : 3113 9.
14. Burnett AF, Roman LD, Garcia AA, Muderspach LI, Brader KR, Morrow CP. A phase II study of gemcitabine and cisplatin in patients with advanced, persistent, or recurrent squamous cell carcinoma of the cervix. Gynecol Oncol 2000 76 : 63 6.
15. Schilder RJ, Blessing JA, Morgan M, Mangan CE, Radar JS. Evaluation of gemcitabine in patients with squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group. Gynecol Oncol 2000 76 : 204 7.
16. Matulonis UA, Campos S, Duska L et al. Phase I/II dose finding study of combination cisplatin and gemcitabine in patients with recurrent cervix cancer. Gynecol Oncol 2006 103 : 160 4.